Validation of the MiCK Assay



Status:Completed
Conditions:Lung Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:June 2012
End Date:March 2015
Contact:Mary Karaus
Email:karaus.mary@mayo.edu
Phone:507-538-8472

Use our guide to learn which trials are right for you!

Mayo Clinic Validation of the MiCK Assay

Testing Mayo Clinic cancer patients with the results being correlated with prior patient
therapy, performance status, and extent of disease.

This study will be conducted in two phases.

During the Feasibility Phase, specimens from any tumor will be sent to the central DiaTech
MiCK assay laboratory to determine the ease of sample acquisition, processing, transport,
and assay interpretation.

Once DiaTech has completed analyses for the feasibility phase specimens and has confirmed
that the sample acquisition, processing, transport, and assay interpretation are
appropriate, we will proceed with the Demonstration Phase.

During the Mesothelioma Demonstration Phase, 20 mesothelioma samples will be assayed and the
results will be correlated with prior patient therapy, performance status, and extent of
disease.

Inclusion Criteria:

- 20 subjects diagnosed with mesothelioma and 10 diagnosed with any malignancy.

Exclusion Criteria:

- patients that a sample cannot obtained for testing.
We found this trial at
1
site
?
mi
from
Rochester, MN
Click here to add this to my saved trials